Clinical trials
Light clinical trials
Below are recruiting light clinical trials, each written for real people, not researchers. We’re tracking 277 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07183644Recruiting
Laser treatment for port-wine birthmarks in children
This study tests how well laser therapy works for children with port-wine stains (red or purple birthmarks). It aims to find the best way to use lasers to lighten or remove these marks safely.
Dallas, TexasAges 2 months–18 years - NCT07223086Recruiting
Tinted contact lenses for concussion light sensitivity
This trial tests if special tinted contact lenses can help reduce light sensitivity caused by a concussion. It may help people who have had a mild concussion in the past two years and are bothered by light.
Birmingham, AlabamaAges 18 years+ - NCT07232459Recruiting
PET imaging for amyloidosis in the heart
This study tests a new PET imaging tracer called [18F]FT8 to see if it can better detect amyloid protein buildup in the heart. It may help doctors diagnose and monitor cardiac amyloidosis more accurately.
Hefei, AnhuiAges 18 years+ - NCT07249918Recruiting
Wearable devices for dementia care in rural Taiwan
This trial tests if wearable devices can help monitor and improve behavioral symptoms like agitation, depression, or sleep problems in people with Alzheimer's or mild cognitive impairment. It also involves their caregivers.
Beigang, YunlinAges Any age - NCT07585760RecruitingPhase 2
Study of CM336 and Isatuximab for new multiple myeloma with kidney problems
This trial tests a combination of two drugs, CM336 and Isatuximab, for people newly diagnosed with multiple myeloma that has caused kidney damage. The goal is to see if this treatment can help control the myeloma while also addressing the kidney issues.
TianjinAges 18–80 - NCT07680335Recruiting
Blood test to help diagnose Alzheimer's earlier
This study is testing whether a simple blood test can help doctors diagnose Alzheimer's disease earlier and more accurately. It's for people who are having memory or thinking problems and are visiting a memory clinic.
Amsterdam, North HollandAges 55 years+ - NCT07081646RecruitingPhase 1/Phase 2
CAR T cell therapy for AL amyloidosis
This trial tests a CAR T cell therapy that targets two proteins (CD19 and BCMA) on the surface of abnormal plasma cells. It is for people with AL amyloidosis whose disease has come back or did not respond to at least one prior treatment.
Phoenix, ArizonaAges 18 years+ - NCT07282080Recruiting
Green light for better body
This trial tests whether exposure to green light can improve your body composition (like muscle and fat ratio). It's a simple, non-invasive study for healthy adults in the U.S.
New York, New YorkAges 18 years+ - NCT07282275Recruiting
Does ongoing green light therapy improve health outcomes?
This trial looks at what happens when people continue using green light therapy over time. It aims to see if ongoing use leads to better health results.
New York, New YorkAges 18 years+ - NCT07298863Recruiting
How hydration affects energy use during rest and exercise
This study looks at how being hydrated or dehydrated changes how your body uses energy (substrate oxidation) when you are resting and doing light or moderate exercise. You will cycle and provide samples to help researchers understand the impact of hydration.
Valhalla, New YorkAges 18–35 - NCT07313410Recruiting
Near-infrared light study for better understanding of PAD
This study uses near-infrared light to learn more about peripheral artery disease (PAD) in adults. It aims to help doctors better understand how PAD affects the body.
Arlington, TexasAges 18 years+ - NCT07329283Recruiting
Nighttime nutrition and sleep health study
This study looks at how eating at night affects your sleep and body clock. You will spend two nights in a sleep lab to test the effects of a small meal before bed.
Salt Lake City, UtahAges 18–35 - NCT07329712Recruiting
Light therapy for dry eye: tear protein study
This trial tests whether low-level light therapy can improve dry eye disease by measuring changes in tear proteins. It may help people with chronic dry eye who are interested in a non-drug treatment.
SingaporeAges 21 years+ - NCT07353216Recruiting
Testing ofatumumab for relapsing multiple sclerosis
This trial tests if ofatumumab can help people with relapsing multiple sclerosis (RMS) by measuring its effect on nerve damage markers in the blood. It aims to see if the drug is safe and effective for controlling relapses and slowing disease activity.
Guangzhou, GuangdongAges 18 years+ - NCT07388602RecruitingPhase 3
New drug combo for newly diagnosed AL amyloidosis
This trial tests a new drug (SCTC21C) combined with three standard chemotherapy medicines for people who have just been diagnosed with AL amyloidosis. The goal is to see if adding the new drug helps reduce the abnormal protein deposits better than the standard treatment alone.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07397754Recruiting
Salty condiments study for blood pressure health
This study tests whether specially designed salty condiments can help manage blood pressure. If your blood pressure is mildly high and you’re not on medication for it, you might be a good fit.
SingaporeAges 50–75 - NCT07417410Recruiting
Diabetes eye disease risk study
This study looks back at medical records of people with type 2 diabetes to understand how diabetic eye disease (retinopathy) progresses and when treatment is needed. It may help doctors better predict risks and guide future care.
Portugal, Coimbra DistrictAges 35–90 - NCT07427537Recruiting
Studying nerve damage from chemotherapy in colorectal and lung cancer patients
This study looks for small molecules in the blood that might predict nerve damage caused by certain chemotherapies. If you have colorectal or lung cancer and are starting a specific chemo plan, this trial could help researchers understand why some people get nerve problems and others don't.
Clermont-FerrandAges 18 years+ - NCT07458516Recruiting
Observing eye disease progression in type 2 diabetes
This study closely follows people with type 2 diabetes who have early signs of diabetic retinopathy (damage to the retina from diabetes) to see how the condition changes over time. It does not test a new treatment but monitors the eye's health closely. It may be a good fit if you have diabetic retinopathy that does not need immediate treatment.
CoimbraAges 35–80 - NCT07474883RecruitingEarly Phase 1
Timolol eye drops for red marks after acne
This trial tests if timolol eye drops, applied to the skin, can reduce red marks left by acne. It may be an option for people with acne-related redness who haven't responded to other treatments.
Ho Chi Minh CityAges 12 years+ - NCT07496918RecruitingPhase 2
Brain effects of light and sound stimulation at 40 Hz
This study tests whether special lights and sounds (at a specific 'gamma' frequency) can safely affect brain activity. It is an early trial looking at how the brain responds to these gentle sensory stimulations.
Cambridge, MassachusettsAges 18–100 - NCT07509177Recruiting
Infrared light therapy for stress in epilepsy
This trial tests if infrared light therapy can help reduce stress in people with epilepsy. You would wear a ring to track your sleep and activity, and attend 45 light therapy sessions over several months.
North Miami, FloridaAges 18 years+ - NCT07606300Recruiting
Light Training to Help Light Sensitivity After Head Injury
This trial tests whether a training program using colored light targets can help reduce light sensitivity (photophobia) that some people experience after a traumatic brain injury. The training involves focusing your eyes on lights during several visits.
Columbus, OhioAges 18–80 - NCT07638683RecruitingPhase 2
Teclistamab and Daratumumab for New Multiple Myeloma With Amyloidosis
This trial tests a combination of two newer cancer-fighting drugs (teclistamab and daratumumab) to treat people who have just been diagnosed with multiple myeloma—a blood cancer—and also have light chain amyloidosis, a condition where abnormal proteins build up in organs. The goal is to see if this combination works better and is safe for newly diagnosed patients.
ShanghaiAges 18 years+
Hear when a new Light trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for light?
- Yes. Clin2 currently lists 277 recruiting light studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a light trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a light trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.